We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals
AMPH

134 hedge funds and large institutions have $478M invested in Amphastar Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 50 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 15

3.57% more ownership

Funds ownership: 47.43% → 51% (+3.6%)

1% more capital invested

Capital invested by funds: $471M → $478M (+$6.53M)

1% more funds holding

Funds holding: 133 → 134 (+1)

6% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 50

96% less call options, than puts

Call options by funds: $19K | Put options by funds: $496K

Holders
134
Holders Change
+1
Holders Change %
+0.75%
% of All Funds
2.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
47
Reduced
50
Closed
15
Calls
$19K
Puts
$496K
Net Calls
-$477K
Net Calls Change
+$19K

Top Buyers

Rank Fund Capital Flow
1
VOYA Investment Management
VOYA Investment Management
Georgia
+$12.2M
2
Marshall Wace
Marshall Wace
United Kingdom
+$8.61M
3
Invesco
Invesco
Georgia
+$8.23M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$5.99M
5
SAM
Silvercrest Asset Management
New York
+$4.81M

Top Sellers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
-$5.65M
2
ACM
Argent Capital Management
Missouri
-$3.97M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.43M
4
Allianz Asset Management
Allianz Asset Management
Germany
-$1.61M
5
Canada Life
Canada Life
Manitoba, Canada
-$979K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$3.48M -$637K -30,565 -15%
MSL
27
Mackay Shields LLC
New York
$3.28M -$333K -16,000 -9%
PPA
28
Parametric Portfolio Associates
Washington
$3.11M -$313K -15,008 -9%
Citadel Advisors
29
Citadel Advisors
Florida
$2.62M +$1.56M +74,767 +131%
First Trust Advisors
30
First Trust Advisors
Illinois
$2.47M +$186K +8,942 +8%
Morgan Stanley
31
Morgan Stanley
New York
$2.37M -$796K -38,237 -24%
Bank of America
32
Bank of America
North Carolina
$2.17M +$1.17M +56,202 +106%
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$2.16M +$28.3K +1,358 +1%
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$2.15M +$828K +39,774 +58%
AllianceBernstein
35
AllianceBernstein
Tennessee
$2.14M -$172K -8,250 -7%
Bessemer Group
36
Bessemer Group
New Jersey
$2.08M +$137K +6,600 +7%
Skandinaviska Enskilda Banken (SEB)
37
Skandinaviska Enskilda Banken (SEB)
Sweden
$1.87M -$183K -8,800 -9%
Public Sector Pension Investment Board (PSP Investments)
38
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.74M +$202K +9,712 +12%
SEI Investments
39
SEI Investments
Pennsylvania
$1.68M – – –
Legal & General Group
40
Legal & General Group
United Kingdom
$1.61M -$39K -1,873 -2%
QI
41
QS Investors
New York
$1.44M – – –
Swiss National Bank
42
Swiss National Bank
Switzerland
$1.31M +$37.5K +1,800 +3%
UBS Group
43
UBS Group
Switzerland
$1.26M +$221K +10,632 +20%
Prudential Financial
44
Prudential Financial
New Jersey
$1.25M -$6.37K -306 -0.5%
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$1.14M +$1.1M +52,777 +1,072%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$1.11M +$13.9K +668 +1%
Millennium Management
47
Millennium Management
New York
$1.07M +$820K +39,389 +266%
State of Wisconsin Investment Board
48
State of Wisconsin Investment Board
Wisconsin
$1.07M +$58.3K +2,800 +5%
Allianz Asset Management
49
Allianz Asset Management
Germany
$1.02M -$1.61M -77,147 -60%
Squarepoint
50
Squarepoint
New York
$971K -$122K -5,880 -11%
1
2
3 4 5

AMPH Hedge Fund Activity: Q3 2019 in Review

134 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q3 2019, worth a combined $478M — up 1.4% from $471M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new AMPH positions and 15 closed out — a net gain of 2 holders — while 47 added to existing stakes and 50 trimmed.

The largest buyer was VOYA Investment Management, adding an estimated $12.2M. The largest seller was Nuveen, cutting an estimated $5.65M.

  • 134 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q3 2019, up from 133 in Q2 2019.
  • Funds reported $478M of Amphastar Pharmaceuticals stock for Q3 2019, up 1.4% quarter-over-quarter.
  • 17 funds opened new Amphastar Pharmaceuticals positions in Q3 2019 and 15 closed out, a net change of +2 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q3 2019 was VOYA Investment Management, an estimated $12.2M added.
  • The largest Amphastar Pharmaceuticals seller in Q3 2019 was Nuveen, an estimated $5.65M sold.

Based on aggregated 13F filings for Q3 2019.